Following the release of nanocomposites from the hydrogel, the nanomicelles (formulated to circulate for prolonged periods in the peritoneal fluid) targeted specific mucin antigens significantly over-expressed on ovarian cancer cells circulating in the peritoneal fluid (when patients are usually diagnosed) and cancer cells forming nodules at distant sites in the peritoneal cavity. Here, MUC5AC is linked to cancer.